Biopharmaceutical Industry in Denmark: Market Research Reports, Statistics and Analysis

Bioporto A/s - Investment Analysis, May 2010

... The test in a testing format other than elisa and concerning access to bioporto S ip and other technology within the apc-pci area. The antibody portfolio revenues generated by the antibody portfolio ...

Company Report: Biopharmaceutical In The United States And Denmar ...

... With chemotherapy versus rituximab in combination with chemotherapy in relapsed or refractory dlbcl, marking the first head to head study of ofatumumab and rituximab. As a result of the achievements ...

Bavarian Nordic A/s - Annual Report 2010

... With a clinically demonstrated strong safety profile for the development of vaccines against various infectious diseases such as smallpox, hiv, as well as against breast and prostate cancer. Bavarian nordic has ...

Genmab A/s - Investment Analysis, November 2010

... The start of a phase iii study of single agent ofatumumab compared to single agent rituximab in patients with follicular non-hodgkin S lymphoma (nhl) that has relapsed at least 6 months after completion ...

Company Report: Biopharmaceutical In Denmark And The United State ...

... Of ofatumumab versus rituximab in rituximab-sensitive follicular nhl that has relapsed at least 6 months after treatment with a rituximab-containing regimen o phase ii study of ofatumumab in previously treated ...

Company Report: Antibody In Norway, Russian Federation And Denmar ...

Company Report: Biopharmaceutical In Denmark For Year 2012

... As, which was founded in 1997 with a focus on research into monoclonal human antibody-therapeutics. In may 2009, pharmexa a/s and affitech as were combined by pharmexa a/s taking over affitech ...

Company Report: Biopharmaceutical In Denmark And Russian Federati ...

... Activities in affitech are antibody discovery and optimization activities and the expenses are classified as research costs. The research phase typically includes the identification of potential molecular ...

The Danish Enzyme Sector

... Method that may reduce the amount of enzyme used and increase enzymatic productivity is to recycle the enzymes [10,11]. Conceptually, the assumption is that by recovering the active enzymes from ...